Literature DB >> 20035840

Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway--do androgens matter?

K Vagnerova1, K Liu, A Ardeshiri, J Cheng, S J Murphy, P D Hurn, P S Herson.   

Abstract

Activation of poly (ADP-ribose) polymerases (PARP) contributes to ischemic damage by causing neuronal nicotinamide adenine dinucleotide (NAD(+)) depletion, release of apoptosis-inducing factor and consequent caspase-independent cell death. PARP-mediated cell death is sexually dimorphic, participating in ischemic damage in the male brain, but not the female brain. We tested the hypothesis that androgen signaling is required for this male-specific neuronal cell death pathway. We observed smaller damage following focal cerebral ischemia (MCAO) in male PARP-1 knockout mice compared to wild type (WT) as well as decreased damage in male mice treated with the PARP inhibitor PJ34. Protection from ischemic damage provided by PJ-34 in WT mice is lost after removal of testicular androgens (CAST) and rescued by androgen replacement. CAST PARP-1 KO mice exhibit increased damage compared to intact male KO mice, an effect reversed by androgen replacement in an androgen receptor-dependent manner. Lastly, we observed that ischemia causes an increase in PARP-1 expression that is diminished in the absence of testicular androgens. Our data indicate that PARP-mediated neuronal cell death in the male brain requires intact androgen-androgen receptor signaling. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035840      PMCID: PMC3098136          DOI: 10.1016/j.neuroscience.2009.12.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

1.  Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production.

Authors:  T Goyagi; S Goto; A Bhardwaj; V L Dawson; P D Hurn; J R Kirsch
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

2.  Neural androgen receptor regulation: effects of androgen and antiandrogen.

Authors:  S Lu; N G Simon; Y Wang; S Hu
Journal:  J Neurobiol       Date:  1999-12

3.  Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model.

Authors:  Shao-Hua Yang; Evelyn Perez; Jason Cutright; Ran Liu; Zhen He; Arthur L Day; James W Simpkins
Journal:  J Appl Physiol (1985)       Date:  2002-01

4.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

5.  Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons.

Authors:  J Hammond; Q Le; C Goodyer; M Gelfand; M Trifiro; A LeBlanc
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

6.  Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism.

Authors:  E Ahlbom; G S Prins; S Ceccatelli
Journal:  Brain Res       Date:  2001-02-23       Impact factor: 3.252

7.  PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury.

Authors:  Henrik Hagberg; Mary Ann Wilson; Hiroko Matsushita; Changlian Zhu; Mary Lange; Malin Gustavsson; Marc F Poitras; Ted M Dawson; Valina L Dawson; Frances Northington; Michael V Johnston
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

8.  Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70.

Authors:  Yan Zhang; Nathalie Champagne; Lenore K Beitel; Cynthia G Goodyer; Mark Trifiro; Andréa LeBlanc
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

9.  Testosterone amplifies excitotoxic damage of cultured oligodendrocytes.

Authors:  A Caruso; V Di Giorgi Gerevini; M Castiglione; F Marinelli; V Tomassini; C Pozzilli; A Caricasole; V Bruno; F Caciagli; A Moretti; F Nicoletti; D Melchiorri
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

10.  Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice.

Authors:  Masayoshi Uchida; Julie M Palmateer; Paco S Herson; A Courtney DeVries; Jian Cheng; Patricia D Hurn
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-13       Impact factor: 6.200

View more
  23 in total

Review 1.  Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.

Authors:  W Ying; Z-G Xiong
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 2.  Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging.

Authors:  Nioka C Chisholm; Farida Sohrabji
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

Review 3.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

4.  Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury.

Authors:  Takeru Shimizu; Tara A Macey; Nidia Quillinan; Jelena Klawitter; Anne-Laure L Perraud; Richard J Traystman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

Review 5.  Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.

Authors:  Xueqing Ba; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 6.  Age and sex differences in the pathophysiology of acute CNS injury.

Authors:  TaeHee Kim; Bharath Chelluboina; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-01-14       Impact factor: 3.921

7.  Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice.

Authors:  S Nakayama; R Vest; R J Traystman; P S Herson
Journal:  J Mol Neurosci       Date:  2013-03-27       Impact factor: 3.444

Review 8.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

9.  Experimental pediatric arterial ischemic stroke model reveals sex-specific estrogen signaling.

Authors:  Paco S Herson; Chris G Bombardier; Susan M Parker; Takeru Shimizu; Jost Klawitter; Jelena Klawitter; Nidia Quillinan; Jennifer L Exo; Neil A Goldenberg; Richard J Traystman
Journal:  Stroke       Date:  2013-01-24       Impact factor: 7.914

Review 10.  Androgens and stroke: good, bad or indifferent?

Authors:  Nidia Quillinan; Guiying Deng; Himmat Grewal; Paco S Herson
Journal:  Exp Neurol       Date:  2014-02-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.